Selected research
Industry Research
Lisdexamfetamine Dimesylate Capsules Industry Research Report 2026
Market perspective
The global Lisdexamfetamine Dimesylate Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lisdexamfetamine Dimesylate Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lisdexamfetamine Dimesylate Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lisdexamfetamine Dimesylate Capsules include Zhejiang Huahai Pharmaceutical, Sun Pharmaceutical, Takeda Pharmaceutical, Teva Pharmaceutical, Sandoz, Mylan, Mallinckrodt PLC, Lannett and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lisdexamfetamine Dimesylate Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lisdexamfetamine Dimesylate Capsules Market by Company
Zhejiang Huahai Pharmaceutical
Sun Pharmaceutical
Takeda Pharmaceutical
Teva Pharmaceutical
Sandoz
Mylan
Mallinckrodt PLC
Lannett
Hikma Pharmaceuticals
Ascent Pharmaceuticals
Apotex
Amneal Pharmaceuticals
Alkem Laboratories
Lisdexamfetamine Dimesylate Capsules Segment by Type
10mg per Unit
20mg per Unit
30mg per Unit
40mg per Unit
50mg per Unit
60mg per Unit
70mg per Unit
Lisdexamfetamine Dimesylate Capsules Segment by Application
Attention Deficit Hyperactivity Disorder(ADHD)
Bulimia
Other
Lisdexamfetamine Dimesylate Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine Dimesylate Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine Dimesylate Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine Dimesylate Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lisdexamfetamine Dimesylate Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lisdexamfetamine Dimesylate Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lisdexamfetamine Dimesylate Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg per Unit
- 20mg per Unit
- 30mg per Unit
- 40mg per Unit
- 50mg per Unit
- 60mg per Unit
- 70mg per Unit
Applications
- Attention Deficit Hyperactivity Disorder(ADHD)
- Bulimia
- Other
Companies covered
- Zhejiang Huahai Pharmaceutical
- Sun Pharmaceutical
- Takeda Pharmaceutical
- Teva Pharmaceutical
- Sandoz
- Mylan
- Mallinckrodt PLC
- Lannett
- Hikma Pharmaceuticals
- Ascent Pharmaceuticals
- Apotex
- Amneal Pharmaceuticals
- Alkem Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lisdexamfetamine Dimesylate Capsules Market Size (2021-2032)
- 2.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales (2021-2032)
- 2.2.3 Global Lisdexamfetamine Dimesylate Capsules Market Average Price (2021-2032)
- 2.3 Lisdexamfetamine Dimesylate Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10mg per Unit
- 2.3.3 20mg per Unit
- 2.3.4 30mg per Unit
- 2.3.5 40mg per Unit
- 2.3.6 50mg per Unit
- 2.3.7 60mg per Unit
- 2.3.8 70mg per Unit
- 2.4 Lisdexamfetamine Dimesylate Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Attention Deficit Hyperactivity Disorder(ADHD)
- 2.4.3 Bulimia
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lisdexamfetamine Dimesylate Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lisdexamfetamine Dimesylate Capsules Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lisdexamfetamine Dimesylate Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Lisdexamfetamine Dimesylate Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Lisdexamfetamine Dimesylate Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lisdexamfetamine Dimesylate Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lisdexamfetamine Dimesylate Capsules, Product Type & Application
- 3.8 Global Manufacturers of Lisdexamfetamine Dimesylate Capsules, Established Date
- 3.9 Global Lisdexamfetamine Dimesylate Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Huahai Pharmaceutical
- 4.1.1 Zhejiang Huahai Pharmaceutical Company Information
- 4.1.2 Zhejiang Huahai Pharmaceutical Business Overview
- 4.1.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Takeda Pharmaceutical
- 4.3.1 Takeda Pharmaceutical Company Information
- 4.3.2 Takeda Pharmaceutical Business Overview
- 4.3.3 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.3.5 Takeda Pharmaceutical Recent Developments
- 4.4 Teva Pharmaceutical
- 4.4.1 Teva Pharmaceutical Company Information
- 4.4.2 Teva Pharmaceutical Business Overview
- 4.4.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.4.5 Teva Pharmaceutical Recent Developments
- 4.5 Sandoz
- 4.5.1 Sandoz Company Information
- 4.5.2 Sandoz Business Overview
- 4.5.3 Sandoz Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.5.5 Sandoz Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Mallinckrodt PLC
- 4.7.1 Mallinckrodt PLC Company Information
- 4.7.2 Mallinckrodt PLC Business Overview
- 4.7.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.7.5 Mallinckrodt PLC Recent Developments
- 4.8 Lannett
- 4.8.1 Lannett Company Information
- 4.8.2 Lannett Business Overview
- 4.8.3 Lannett Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.8.5 Lannett Recent Developments
- 4.9 Hikma Pharmaceuticals
- 4.9.1 Hikma Pharmaceuticals Company Information
- 4.9.2 Hikma Pharmaceuticals Business Overview
- 4.9.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.9.5 Hikma Pharmaceuticals Recent Developments
- 4.10 Ascent Pharmaceuticals
- 4.10.1 Ascent Pharmaceuticals Company Information
- 4.10.2 Ascent Pharmaceuticals Business Overview
- 4.10.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.10.5 Ascent Pharmaceuticals Recent Developments
- 4.11 Apotex
- 4.11.1 Apotex Company Information
- 4.11.2 Apotex Business Overview
- 4.11.3 Apotex Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.11.5 Apotex Recent Developments
- 4.12 Amneal Pharmaceuticals
- 4.12.1 Amneal Pharmaceuticals Company Information
- 4.12.2 Amneal Pharmaceuticals Business Overview
- 4.12.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.12.5 Amneal Pharmaceuticals Recent Developments
- 4.13 Alkem Laboratories
- 4.13.1 Alkem Laboratories Company Information
- 4.13.2 Alkem Laboratories Business Overview
- 4.13.3 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio
- 4.13.5 Alkem Laboratories Recent Developments
5 Global Lisdexamfetamine Dimesylate Capsules Market Scenario by Region
- 5.1 Global Lisdexamfetamine Dimesylate Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021-2032
- 5.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021-2026
- 5.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2027-2032
- 5.3 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2027-2032
- 5.4 North America Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country
- 5.4.1 North America Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
- 5.4.3 North America Lisdexamfetamine Dimesylate Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country
- 5.5.1 Europe Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Lisdexamfetamine Dimesylate Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lisdexamfetamine Dimesylate Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country
- 5.7.1 South America Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
- 5.7.3 South America Lisdexamfetamine Dimesylate Capsules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032)
- 6.1.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Lisdexamfetamine Dimesylate Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032)
- 7.1.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Lisdexamfetamine Dimesylate Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lisdexamfetamine Dimesylate Capsules Value Chain Analysis
- 8.1.1 Lisdexamfetamine Dimesylate Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lisdexamfetamine Dimesylate Capsules Production Mode & Process
- 8.2 Lisdexamfetamine Dimesylate Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lisdexamfetamine Dimesylate Capsules Distributors
- 8.2.3 Lisdexamfetamine Dimesylate Capsules Customers
9 Global Lisdexamfetamine Dimesylate Capsules Analyzing Market Dynamics
- 9.1 Lisdexamfetamine Dimesylate Capsules Industry Trends
- 9.2 Lisdexamfetamine Dimesylate Capsules Industry Drivers
- 9.3 Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges
- 9.4 Lisdexamfetamine Dimesylate Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst